Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

APP Institute Oncology

Featured

Samantha Shenoy
Videos
Management Considerations for Oral Toxicities Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
05/09/2024
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses...
05/09/2024
APP Institute Oncology
Sarah Smith, Virginia Cancer Specialists
Videos
Post-Progression and Safety Outcomes With First-Line Amivantamab Plus Lazertinib vs Osimertinib for Advanced NSCLC: Best Management Practices
05/08/2024
Sarah Smith, BD, CNMT, discusses findings from the phase 3 MARIPOSA study exploring post-progression and safety outcomes with first-line amivantamab plus lazertinib vs osimertinib for advanced NSCLC and offers guidance for best management...
Sarah Smith, BD, CNMT, discusses findings from the phase 3 MARIPOSA study exploring post-progression and safety outcomes with first-line amivantamab plus lazertinib vs osimertinib for advanced NSCLC and offers guidance for best management...
Sarah Smith, BD, CNMT, discusses...
05/08/2024
APP Institute Oncology
EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
11/27/2023

Featuring Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD

Featuring Elizabeth Finley-Oliver, MS...
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
APP Institute Oncology
EGFR
Rapid Refresh
Understanding the Role of EGFR in Cancer Pathogenesis
11/23/2023
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role...
11/23/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023

Featuring Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP

Featuring Lorinda Coombs, PhD, CNS, F...
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology
Oncology Advances: Adverse Event Management Strategies for Patients With MM Receiving Talquetamab
A recent study by Donna Catamero, Mount Sinai School of Medicine, New York, New York, et al, provides guidance on practical management of patients with relapsed/refractory MM receiving ta...
CD19
Rapid Refresh
Understanding the Role of CD19 in Cancer Pathogenesis
11/09/2023
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role...
11/09/2023
APP Institute Oncology
BTK
Rapid Refresh
Understanding the Role of BTK in Cancer Pathogenesis
11/09/2023
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role...
11/09/2023
APP Institute Oncology
HER2
Rapid Refresh
Understanding the Role of HER2 in Cancer Pathogenesis
11/08/2023
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role...
11/08/2023
APP Institute Oncology

Advertisement

Advertisement

Rapid Refresh

BCMA
Rapid Refresh
Understanding the Role of BCMA in Cancer Pathogenesis
07/23/2024
This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.
This animation explains the role of BCMA in the life cycle of plasma cells and the effects of overexpression of BCMA on the abnormal survival of these cells.
This animation explains the role...
07/23/2024
APP Institute Oncology
BCL2
Rapid Refresh
Understanding the Role of BCL2 in Cancer Pathogenesis
07/23/2024
This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.
This animation discusses the role of BCL2 in normal cell function and explains the effects of disruptions in the BCL2 gene on cell signaling.
This animation discusses the...
07/23/2024
APP Institute Oncology
ALK
Rapid Refresh
Understanding the Role of ALK in Cancer Pathogenesis
07/23/2024
This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.
This animation explains the role of the ALK oncogene in normal cellular functioning and the effect of an abnormal translocation event where ALK fuses to another gene.
This animation explains the role...
07/23/2024
APP Institute Oncology
20S Proteasome
Rapid Refresh
Understanding the Role of 20S Proteasome in Cancer Pathogenesis
07/23/2024
This animation explains the role of the 20S proteasome in regulating the cellular life cycle and the effects of disruptions in the ubiquitin proteasome system.
This animation explains the role of the 20S proteasome in regulating the cellular life cycle and the effects of disruptions in the ubiquitin proteasome system.
This animation explains the role...
07/23/2024
APP Institute Oncology
CEACAM5
Rapid Refresh
Understanding the Role of CEACAM5 in Cancer Pathogenesis
07/08/2024
This animation explains the role of the CEACAM5 glycoprotein in the inhibition of cell differentiation and apoptosis, which can promote tumor growth and metastasis.
This animation explains the role of the CEACAM5 glycoprotein in the inhibition of cell differentiation and apoptosis, which can promote tumor growth and metastasis.
This animation explains the role...
07/08/2024
APP Institute Oncology
EZH2
Rapid Refresh
Understanding the Role of EZH2 in Cancer Pathogenesis
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
EGFR
Rapid Refresh
Understanding the Role of EGFR in Cancer Pathogenesis
11/23/2023
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role of EGFR in the regulation of cell growth and the effects of the overexpression of EGFR.
This animation explains the role...
11/23/2023
APP Institute Oncology
CD19
Rapid Refresh
Understanding the Role of CD19 in Cancer Pathogenesis
11/09/2023
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role of the CD19 antigen in the primary signaling complex on the surface of B-cells and the effect of overexpression of this antigen.
This animation explains the role...
11/09/2023
APP Institute Oncology
BTK
Rapid Refresh
Understanding the Role of BTK in Cancer Pathogenesis
11/09/2023
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role of Bruton's tyrosine kinase (BTK) in B-cell development and maturation and the effects of aberrant expression of this oncogene.
This animation explains the role...
11/09/2023
APP Institute Oncology
HER2
Rapid Refresh
Understanding the Role of HER2 in Cancer Pathogenesis
11/08/2023
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role of HER2 in the regulation of cell growth and the negative effects of HER2 overexpression.
This animation explains the role...
11/08/2023
APP Institute Oncology

Advertisement

APP Perspectives

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023

Featuring Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP

Featuring Lorinda Coombs, PhD, CNS, F...
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Advertisement

Meeting Coverage

Conference Coverage
Examining the Mental Health Needs of Patients With MDS and Their Caregivers
04/28/2024

Amber Denham

Amber Denham
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the...
04/28/2024
APP Institute Oncology
Conference Coverage
Mobile Health Application for Chronic GVHD Symptom Tracking in Patients Undergoing Allogeneic Transplant
04/27/2024

Janelle Bradley

Janelle Bradley
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the...
04/27/2024
APP Institute Oncology
Conference Coverage
DASH Model Yields Improved Detection of Deterioration Among Patients Undergoing Hematopoietic Cell Transplantation
04/26/2024

Gina Tomaine

Gina Tomaine
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model...
04/26/2024
APP Institute Oncology
Conference Coverage
Gut Microbial Composition, Diversity and Gastrointestinal Symptoms Among Patients With Breast Cancer
04/26/2024

Allison Casey

Allison Casey
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented...
04/26/2024
APP Institute Oncology
Conference Coverage
Exploring Benefits of Categorizing Symptom Clusters Among Younger vs Older Patients Undergoing Chemotherapy
04/26/2024

Amber Denham

Amber Denham
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core...
04/26/2024
APP Institute Oncology
Conference Coverage
Objective Assessment Tool Enables Oncology Nurses to Escalate Treatment-Related Concerns to Physicians
04/25/2024

Stephanie Holland

Stephanie Holland
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid...
04/25/2024
APP Institute Oncology
Conference Coverage
Standardized Screening Tool Demonstrates Benefits to Palliative Care for Oncologic ICU Patients
04/25/2024

Gina Tomaine

Gina Tomaine
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized...
04/25/2024
APP Institute Oncology
Conference Coverage
Researchers Develop Survey to Better Measure Oncology Nurses’ Professional Quality of Life
04/25/2024

Janelle Bradley

Janelle Bradley
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey,...
04/25/2024
APP Institute Oncology
Conference Coverage
CASH Assessment Tool Shows Benefit of Holistic Communication for RN Navigators
04/25/2024

Allison Casey

Allison Casey
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH...
04/25/2024
APP Institute Oncology
Conference Coverage
The 49th Annual Oncology Nursing Society (ONS) Congress Kicks Off in Washington, DC
04/24/2024
The 49th Annual Oncology Nursing Society (ONS) Congress kicks off, offering learning, networking, and celebrating of the oncology nursing profession.
The 49th Annual Oncology Nursing Society (ONS) Congress kicks off, offering learning, networking, and celebrating of the oncology nursing profession.
The 49th Annual Oncology Nursing...
04/24/2024
APP Institute Oncology

Advertisement

Advertisement

Visit Our Other APP Institutes

Advertisement

Advertisement

APP Institute Oncology

 

The Advanced Practice Provider (APP) Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement